Skip to content

MEDA BRIGHT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDA BRIGHT

BE 0705.993.912
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€178,012
2024 · -€257,396+€435,408
Equity
€106,648
2024 · -€71,364+€178,012
Cash
€88,032
2024 · €107,219-€19,186
Balance sheet total
€469,972
2024 · €619,123-€149,151

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€113,218

    down €113,218 (-25.3%), from €447,539 to €334,321

    of which Trade receivables: -€74,022

  • Cash -€19,186

    down €19,186 (-17.9%), from €107,219 to €88,032

    mainly Trade debts (-€314,729) and Current portion of long-term debt (-€12,050)

  • Deferred charges and accrued income -€11,839

    down €11,839 (-64.3%), from €18,420 to €6,581

Equity and liabilities
  • Trade debts -€314,729

    down €314,729 (-48.0%), from €655,440 to €340,711

  • Profit (loss) carried forward +€178,012

    up €178,012, from -€92,364 to €85,648

  • Current portion of long-term debt -€12,050

    no longer reported in 2025 (was €12,050)

Income statement
  • Gross operating margin +€432,870

    up €432,870, from -€209,827 to €223,043

  • Financial charges -€12,060

    down €12,060 (-96.5%), from €12,492 to €432

  • Financial income -€10,767

    down €10,767 (-98.1%), from €10,974 to €206

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€257,396
Gross operating margin +€432,870
Staff costs +€1,153
Depreciation -€1,632
Other operating charges +€1,707
Financial income -€10,767
Financial charges +€12,060
Taxes +€18
Result 2025 €178,012
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€4,867
Investment -€2,269
Financing -€12,050
Cash 2024 €107,219
Net result for the year +€178,012
Depreciation +€6,600
Smaller working-capital items +€193
Receivables within one year +€113,218
Deferred charges and accrued income +€11,839
Trade debts -€314,729
Investment in fixed assets (net) -€2,269
Current portion of long-term debt -€12,050
Cash 2025 €88,032
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €619,123 €469,972 -€149,151 -24.1%
Fixed assets 21/28 €43,682 €39,350 -€4,332 -9.9%
Tangible fixed assets 22/27 €42,966 €38,634 -€4,332 -10.1%
Plant, machinery and equipment 23 €39,987 €35,656 -€4,331 -10.8%
Furniture and vehicles 24 €2,979 €2,979 -€0 0.0%
Financial fixed assets 28 €716 €716 = 0.0%
Current assets 29/58 €575,441 €430,621 -€144,820 -25.2%
Stocks and contracts in progress 3 €2,263 €1,687 -€576 -25.5%
Stocks 30/36 €2,263 €1,687 -€576 -25.5%
Amounts receivable within one year 40/41 €447,539 €334,321 -€113,218 -25.3%
Trade receivables 40 €397,877 €323,856 -€74,022 -18.6%
Other amounts receivable 41 €49,662 €10,465 -€39,196 -78.9%
Cash at bank and in hand 54/58 €107,219 €88,032 -€19,186 -17.9%
Deferred charges and accrued income 490/1 €18,420 €6,581 -€11,839 -64.3%
Total equity and liabilities 10/49 €619,123 €469,972 -€149,151 -24.1%
Equity 10/15 -€71,364 €106,648 +€178,012
Contributions 10/11 €21,000 €21,000 = 0.0%
Contributions outside capital 11 - €21,000 +€21,000
Other 1109/19 - €21,000 +€21,000
Profit (loss) carried forward 14 -€92,364 €85,648 +€178,012
Amounts payable 17/49 €690,487 €363,324 -€327,163 -47.4%
Amounts payable within one year 42/48 €688,214 €360,924 -€327,290 -47.6%
Current portion of amounts payable after more than one year 42 €12,050 - -€12,050
Trade debts 44 €655,440 €340,711 -€314,729 -48.0%
Suppliers 440/4 €655,440 €340,711 -€314,729 -48.0%
Taxes, remuneration and social security 45 €8,806 €8,640 -€166 -1.9%
Taxes 450/3 €439 €2,279 +€1,840 +420%
Remuneration and social security 454/9 €8,368 €6,361 -€2,007 -24.0%
Other amounts payable 47/48 €11,918 €11,573 -€344 -2.9%
Accrued charges and deferred income 492/3 €2,273 €2,400 +€127 +5.6%
Remuneration, social security and pensions 62 €36,811 €35,658 -€1,153 -3.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,968 €6,600 +€1,632 +32.9%
Other operating charges 640/8 €3,964 €2,257 -€1,707 -43.1%
Gross operating margin 9900 -€209,827 €223,043 +€432,870
Operating profit (loss) 9901 -€255,570 €178,528 +€434,098
Financial income 75/76B €10,974 €206 -€10,767 -98.1%
Recurring financial income 75 €10,974 €206 -€10,767 -98.1%
Financial charges 65/66B €12,492 €432 -€12,060 -96.5%
Recurring financial charges 65 €12,492 €432 -€12,060 -96.5%
Profit (loss) for the period before taxes 9903 -€257,088 €178,302 +€435,390
Income taxes 67/77 €308 €290 -€18 -5.7%
Profit (loss) for the period 9904 -€257,396 €178,012 +€435,408
Profit (loss) for the period to be appropriated 9905 -€257,396 €178,012 +€435,408

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.